Stockscreener 앱 받기
6.58
3.66%
-0.25
전일 마감가:
$6.83
열려 있는:
$6.605
하루 거래량:
17,614
Relative Volume:
0.71
시가총액:
$24.90M
수익:
$22.03M
순이익/손실:
$-19.91M
주가수익비율:
-0.3554
EPS:
-18.5136
순현금흐름:
$-16.84M
1주 성능:
-0.75%
1개월 성능:
+9.58%
6개월 성능:
-31.33%
1년 성능:
-59.98%
1일 변동 폭
$6.15
$6.605
1주일 범위
$6.12
$6.90
52주 변동 폭
$4.14
$18.60
Lifeward Ltd Stock (LFWD) Company Profile
명칭
Lifeward Ltd
전화
15082511154
주소
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.58 | 24.90M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 개시 | Laidlaw | Buy |
| 2017-04-03 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 개시 | Oppenheimer | Outperform |
| 2016-07-15 | 개시 | Piper Jaffray | Overweight |
| 2015-05-22 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 재확인 | Barclays | Equal Weight |
| 2014-10-07 | 개시 | Barclays | Equal Weight |
모두보기
Lifeward Ltd 주식(LFWD)의 최신 뉴스
Sell Signal: Does Lifeward Ltd offer margin of safety2026 Risk Factors & Technical Buy Zone Confirmation - baoquankhu1.vn
Big Picture: Will Lifeward Ltd benefit from government policyForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
S P Trends: Is Lifeward Ltd stock heavily shorted2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - Investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Lifeward (LFWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - Stock Titan
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - MarketScreener
If You Invested $1,000 in Lifeward Ltd (LFWD) - Stock Titan
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - tradingview.com
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - GuruFocus
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Lifeward Ltd (LFWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
0.34%
자본화:
|
볼륨(24시간):